...
首页> 外文期刊>British Journal of Cancer >Natural history of cervical neoplasia: consistent results obtained by an identification technique
【24h】

Natural history of cervical neoplasia: consistent results obtained by an identification technique

机译:宫颈肿瘤的自然病程:通过鉴定技术获得的一致结果

获取原文

摘要

Swedish population-based incidence and mortality rates for cancer of the uterine cervix, both in situ and invasive, during the period 1958 to 1981 were determined by means of a dynamic model. This new approach describes without any preconceptions the development of the disease as a sequential process over the stages cancer in situ, invasive cancer before and after diagnosis, and death. The strong disturbance of the steady-state situation that occurred after the introduction of cytological mass screening in the early 1960s permitted the use of a computerized identification technique. The whole natural history of cervical cancer could thus be identified and described consistently, with the mutual compatibility between statistical data, structure, parameters, and the states and flows between the states. The estimated age-specific incidence of cancer in situ increased rapidly to a maximum of 650 per 10(5) woman-years at the age of 30 years, after which it declined, and that of invasive cancer to a maximum of 55 per 10(5) at the age of 43. The natural history of cervical neoplasia did not differ appreciably between eight successive 5-year birth cohorts. The proportion of cases of new cancer in situ that progressed to invasive cancer was 12.2%, with a mean duration of the in situ stage in these cases of 13.3 years. The preclinical phase of the invasive stage (without screening) lasted on average about 4 years.
机译:通过动态模型确定了瑞典在1958年至1981年间基于人群的原位和浸润性宫颈癌发病率和死亡率。这种新方法没有任何先入之见地将疾病的发展描述为原位癌,诊断前后的浸润性癌以及死亡的顺序过程。在1960年代初期引入细胞学质量筛选后,对稳态情况的强烈干扰允许使用计算机识别技术。因此,通过统计数据,结构,参数以及状态和状态之间的相互兼容,可以一致地识别和描述宫颈癌的整个自然历史。在30岁时,估计的原位年龄特定年龄的癌症发病率迅速增加,至每10(5)个女性年最高650,然后下降;而浸润性癌症的发病率则最高至每10(55)女性55。 5)43岁。连续8个5岁出生队列的子宫颈癌的自然病程没有明显差异。进展为浸润性癌症的原位新癌病例比例为12.2%,在这些病例中,原位平均病程为13.3年。侵入性阶段的临床前阶段(不进行筛查)平均持续约4年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号